INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,010,000 | +224.8% | 40,000 | +176.1% | 0.00% | – |
| Q3 2022 | $311,000 | -43.8% | 14,489 | -25.5% | 0.00% | – |
| Q2 2021 | $553,000 | -11.0% | 19,444 | +6.6% | 0.00% | -100.0% |
| Q1 2021 | $621,000 | +74.9% | 18,244 | +49.5% | 0.00% | – |
| Q1 2019 | $355,000 | +13.8% | 12,203 | -48.6% | 0.00% | – |
| Q4 2018 | $312,000 | -82.5% | 23,747 | -73.0% | 0.00% | -100.0% |
| Q3 2018 | $1,779,000 | +97.9% | 88,000 | +131.6% | 0.00% | 0.0% |
| Q2 2018 | $899,000 | +152.5% | 38,000 | +232.6% | 0.00% | – |
| Q4 2017 | $356,000 | -84.6% | 11,424 | -84.5% | 0.00% | -100.0% |
| Q3 2017 | $2,305,000 | +2252.0% | 73,869 | +1273.0% | 0.00% | – |
| Q4 2015 | $98,000 | +188.2% | 5,380 | +215.0% | 0.00% | – |
| Q2 2014 | $34,000 | – | 1,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |